Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation
Status: | Recruiting |
---|---|
Conditions: | Women's Studies, Infertility |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 18 - 37 |
Updated: | 5/6/2018 |
Start Date: | July 2016 |
End Date: | December 2019 |
Contact: | Asima K Ahmad, MD, MPH |
Email: | asima.ahmad@ucsf.edu |
Phone: | 4153537475 |
Randomized Controlled Trial Comparing Intra-vaginal Culture of Embryos Using INVOcell Device to In-vitro Culture of Embryos Using Minimal Stimulation Protocols
The purpose of this study is to evaluate implantation rate with intra-vaginal culture with
the INVOcell device versus traditional IVF while using minimal stimulation protocols
the INVOcell device versus traditional IVF while using minimal stimulation protocols
This is a Phase IV, single center randomized controlled trial evaluating intra-vaginal
culture using INVOcell versus traditional IVF using oral stimulation or minimal gonadotropin
stimulation protocols. The pilot aims to includes 40 women who will be randomized to either
the intra-vaginal culture group (N=20) using INVOcell or to the traditional IVF group (N=20).
Primary aim is implantation rate, which is defined by number gestational sacs seen on early
pregnancy ultrasound divided by number of embryos transferred.
Secondary aims are:
- Embryo quality, which is measured by the Gardner grading system.
- Fertilization rate, which is defined by the total number of fertilized oocytes divided
by total number of mature oocytes retrieved. This comparison will take place on day-3,
as that is when the IVC embryos will be assessed.
- Clinical pregnancy rate, which is defined by the number of fetal poles with heartbeat
seen on ultrasound divided by the number of embryos transferred.
- Live birth rate, which is defined by the number of living babies delivered divided by
the number of transfers
culture using INVOcell versus traditional IVF using oral stimulation or minimal gonadotropin
stimulation protocols. The pilot aims to includes 40 women who will be randomized to either
the intra-vaginal culture group (N=20) using INVOcell or to the traditional IVF group (N=20).
Primary aim is implantation rate, which is defined by number gestational sacs seen on early
pregnancy ultrasound divided by number of embryos transferred.
Secondary aims are:
- Embryo quality, which is measured by the Gardner grading system.
- Fertilization rate, which is defined by the total number of fertilized oocytes divided
by total number of mature oocytes retrieved. This comparison will take place on day-3,
as that is when the IVC embryos will be assessed.
- Clinical pregnancy rate, which is defined by the number of fetal poles with heartbeat
seen on ultrasound divided by the number of embryos transferred.
- Live birth rate, which is defined by the number of living babies delivered divided by
the number of transfers
Inclusion Criteria:
- Normal uterine cavity
- One or more years of infertility
- Normal male partner semen analysis
Exclusion Criteria:
- Age <18 years old or >37 years old
- AFC <8
- Abnormal male partner semen analysis or use of donor sperm
- Vaginal inflammation or genital (vaginal, uterine, tubal) infection
- Uncontrolled chronic disease (such as uncontrolled diabetes or hypertension)
- Uterine anatomic abnormalities
- Allergy to plastics or inability to use diaphragm retention device
- Untreated hydrosalpinx
- Current alcohol abuse (defined by >14 drinks/week)
- Prior history of IVF cycle where fertilization did not occur
- History of recurrent pregnancy loss
We found this trial at
1
site
San Francisco, California 94158
Phone: 415-353-7475
Click here to add this to my saved trials